tiprankstipranks
Trending News
More News >
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
US Market

Spero Therapeutics (SPRO) Cash flow

Compare
519 Followers

Spero Therapeutics Cash Flow

SPRO's free cash flow for Q3 2024 was $12.76M. For the 2024 fiscal year, SPRO's free cash flow was decreased by $9.55M and operating cash flow was $12.76M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -23.44M$ -32.99M$ -7.73M$ -64.35M$ -85.87M
Investing Cash Flow
$ 0.00$ 0.00$ 33.81M$ 7.67M$ 10.47M
Financing Cash Flow
$ 0.00$ 221.00K$ -29.55M$ 84.05M$ 130.88M
End Cash Position
$ 52.89M$ 76.33M$ 109.11M$ 112.58M$ 85.21M
Free Cash Flow
$ -23.44M$ -32.99M$ -7.73M$ -64.31M$ -86.03M
Currency in USD

Spero Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis